Close Menu
June 10, 2020
Sponsored by

Leveraging the Power of Synthetic Biology to Accelerate Precision Immunotherapy Research and Delivery


Professor, Division of Cellular Immunology, La Jolla Institute for Allergy and Immunology & Head of Cancer Vaccines, Human Longevity Inc.

Medical Oncologist & Assistant Professor of Medicine, UC San Diego Health


T-cell receptor (TCR) therapy is a rapidly emerging adaptive cell therapy (ACT) method in the field of cancer immunotherapy. However, the process for developing effective T-cell receptors can be time consuming, particularly with regard to the rigorous functional testing needed prior to scale-up and patient infusion.

In this webinar, Stephen Schoenberger of the La Jolla Institute for Immunology discusses how he is leveraging an automated DNA assembly and cloning platform, the BioXp 3200, to achieve a 10-fold increase in the development of TCRs.


Sponsored by